George S K, Uttenthal L O, Ghiglione M, Bloom S R
FEBS Lett. 1985 Nov 18;192(2):275-8. doi: 10.1016/0014-5793(85)80124-1.
Molecular forms of the glucagon-like peptides (GLP) encoded by the human preproglucagon gene were analysed by chromatography combined with specific radioimmunoassays to the synthetic peptides. Whereas extracts of human pancreas and a glucagonoma contained a large proglucagon cleavage product possessing both GLP-1 and GLP-2 immunoreactivities, extracts of human intestine contained products corresponding to free GLP-1 and a small amount of chromatographically distinct GLP-2 immunoreactivity. It is concluded that post-translational processing of proglucagon differs in pancreas and intestine, so that the C-terminal portion of the molecule is cleaved to liberate free GLP-1 in the intestine. Further processing or degradation results in loss especially of GLP-2 immunoreactivity.
通过色谱法结合针对合成肽的特异性放射免疫分析法,对人胰高血糖素原基因编码的胰高血糖素样肽(GLP)的分子形式进行了分析。人胰腺提取物和一种胰高血糖素瘤含有一种大的胰高血糖素原裂解产物,同时具有GLP-1和GLP-2免疫反应性,而人肠道提取物含有与游离GLP-1相对应的产物以及少量色谱上不同的GLP-2免疫反应性物质。得出的结论是,胰高血糖素原的翻译后加工在胰腺和肠道中有所不同,因此该分子的C末端部分在肠道中被切割以释放游离的GLP-1。进一步的加工或降解尤其导致GLP-2免疫反应性的丧失。